Versi E - Search Results

1

Does urinary urgency drive urinary frequency in overactive bladder?

Versi E, Rovner ES, Dmochowski RR, Tu LM, De Wachter S. Versi E, et al. Low Urin Tract Symptoms. 2022 Jul;14(4):242-247. doi: 10.1111/luts.12427. Epub 2022 Feb 28. Low Urin Tract Symptoms. 2022. PMID: 35233968

2

Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder.

De Wachter S, Benson KD, Dmochowski RR, Rovner ES, Versi E, Miller LE, Tu LM. De Wachter S, et al. Among authors: versi e. J Urol. 2019 Mar;201(3):573-580. doi: 10.1016/j.juro.2018.09.043. J Urol. 2019. PMID: 30240691

3

Re: Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder.

De Wachter S, Benson KD, Dmochowski RR, Rovner ES, Versi E, Miller LE, Tu LM. De Wachter S, et al. Among authors: versi e. J Urol. 2019 Apr 8:101097JU0000000000000274. doi: 10.1097/JU.0000000000000274. Online ahead of print. J Urol. 2019. PMID: 30958745 No abstract available.

4

One-year results with selective bladder denervation in women with refractory overactive bladder.

Rovner ES, Versi E, Le Mai T, Dmochowski RR, De Wachter S. Rovner ES, et al. Among authors: versi e. Neurourol Urodyn. 2019 Nov;38(8):2178-2184. doi: 10.1002/nau.24110. Epub 2019 Jul 29. Neurourol Urodyn. 2019. PMID: 31359508

5

A Preliminary Study on the Impact of Detrusor Overactivity on the Efficacy of Selective Bladder Denervation for the Treatment of Female Refractory Overactive Bladder.

Brière R, Versi E, Richard PO, Gratton M, Tu LM. Brière R, et al. Among authors: versi e. Urology. 2020 Feb;136:88-94. doi: 10.1016/j.urology.2019.08.061. Epub 2019 Nov 30. Urology. 2020. PMID: 31794815

6

AUTHOR REPLY.

Brière R, Versi E, Richard PO, Gratton M, Tu LM. Brière R, et al. Among authors: versi e. Urology. 2020 Feb;136:94. doi: 10.1016/j.urology.2019.08.065. Urology. 2020. PMID: 32033687 No abstract available.

7

Outcomes of a single trigone-only vs. 20 trigone-sparing injections of OnabotulinumtoxinA for refractory overactive bladder (OAB).

Ton J, Downing P, Versi E, van Uem S, Ephraim S, Murphy M, Lucente V. Ton J, et al. Among authors: versi e. Int Urol Nephrol. 2021 Jun;53(6):1067-1072. doi: 10.1007/s11255-021-02802-0. Epub 2021 Mar 19. Int Urol Nephrol. 2021. PMID: 33742316

8

Efficacy of an external urethral device in women with genuine stress urinary incontinence.

Versi E, Harvey MA. Versi E, et al. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(5):271-4. doi: 10.1007/BF01901505. Int Urogynecol J Pelvic Floor Dysfunct. 1998. PMID: 9849759 Clinical Trial.

9

Clinical Efficacy and Tolerability of the Nicotinic Channel Modulator Dexmecamylamine in Subjects with Overactive Bladder.

Chancellor M, Versi E, Dvergsten C, Toler S. Chancellor M, et al. Among authors: versi e. J Urol. 2015 Nov;194(5):1329-35. doi: 10.1016/j.juro.2015.06.035. Epub 2015 Jun 12. J Urol. 2015. PMID: 26073872 Clinical Trial.

10

Androgen deficiency and stress urinary incontinence.

Kreydin E, Siddle N, Versi E. Kreydin E, et al. Among authors: versi e. Int Urogynecol J. 2022 May;33(5):1353. doi: 10.1007/s00192-022-05116-6. Epub 2022 Mar 14. Int Urogynecol J. 2022. PMID: 35286426 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters